Fertility and Sterility
Volume 91, Issue 3 , Pages 869-877 , March 2009

The p21 codon 31∗C- and DRD2 codon 313∗T-related genotypes/alleles, but not XRCC1 codon 399, hOGG1 codon 326, and DRD1-48 polymorphisms, are correlated with the presence of leiomyoma

  • Yao-Yuan Hsieh, M.D., Ph.D.

      Affiliations

    • Department of Obstetrics and Gynecology, China Medical University Hospital, Taipei, Taiwan, People's Republic of China
    • ,
  • Chi-Chen Chang, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, China Medical University Hospital, Taipei, Taiwan, People's Republic of China
    • ,
  • Da-Tian Bau, Ph.D.

      Affiliations

    • Department of Medical Research, China Medical University Hospital, Taipei, Taiwan, People's Republic of China
    • Graduate Institute of Chinese Medical Science, China Medical University, Taipei, Taiwan, People's Republic of China
    • ,
  • Fuu-Jen Tsai, M.D., Ph.D.

      Affiliations

    • Department of Medical Research, China Medical University Hospital, Taipei, Taiwan, People's Republic of China
    • Graduate Institute of Chinese Medical Science, China Medical University, Taipei, Taiwan, People's Republic of China
    • Corresponding Author InformationReprints requests: Fuu-Jen Tsai, M.D., Ph.D., Department of Pediatrics and Medical Genetics, China Medical University Hospital, No. 2 Yuh-Der Road, Taichung, Taiwan, People's Republic of China (FAX: 886-4-22033295).
    • ,
  • Chang-Hai Tsai, M.D., Ph.D.

      Affiliations

    • Department of Medical Research, China Medical University Hospital, Taipei, Taiwan, People's Republic of China
    • Taichung Health Care and Management University, Taichung, Taiwan, China
    • ,
  • Chih-Ping Chen, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Mackay Memorial Hospital, Taipei, Taiwan, People's Republic of China

Received 13 May 2007 ,Revised 12 July 2007 ,Accepted 12 July 2007.

References 

  1. Cramer DW. Epidemiology of myomas. Semin Reprod Endocrinol. 1992;10:320–324
  2. Townsend DE, Sparkes RS, Baluda MC, McClelland G. Unicellular histogenesis of uterine leiomyomas as determined by electrophoresis by glucose-6-phosphate dehydrogenase. Am J Obstet Gynecol. 1970;107:1168–1173
  3. Rein MS. Advances in uterine leiomyoma research: the progesterone hypothesis. Environ Health Perspect. 2000;108(Suppl 5):791–793
  4. Harris CC, Hollstein M. Clinical implications of the p53 tumor-suppressor gene. N Engl J Med. 1993;329:1318–1327
  5. Li YJ, Laurent-Puig P, Salmon RJ, Thomas G, Hamelin R. Polymorphisms and probable lack of mutation in the WAF1-CIP1 gene in colorectal cancer. Oncogene. 1995;10:599–601
  6. el-Deiry WS, Tokino T, Waldman T, Oliner JD, Velculescu VE, Burrell M, et al. Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res. 1995;55:2910–2919
  7. Li X, Jiao S, Mi R. Clinical significance of p21H-ras expression and H-ras codon 12 mutation in squamous intraepithelial lesion (SIL) and carcinoma of uterine cervix. Chung Hua Chung Liu Tsa Chih. 1997;19:306–308
  8. Levesque MA, Katsaros D, Massobrio M, Genta F, Yu H, Richiardi G, et al. Evidence for a dose-response effect between p53 (but not p21WAF1/Cip1) protein concentrations, survival, and responsiveness in patients with epithelial ovarian cancer treated with platinum-based chemotherapy. Clin Cancer Res. 2000;6:3260–3270
  9. Jahnson S, Karlsson MG. Tumor mapping of regional immunostaining for p21, p53, and mdm2 in locally advanced bladder carcinoma. Cancer. 2000;89:619–629
  10. Cheng L, Lloyd RV, Weaver AL, Pisansky TM, Cheville JC, Ramnani DM, et al. The cell cycle inhibitors p21WAF1 and p27KIP1 are associated with survival in patients treated by salvage prostatectomy after radiation therapy. Clin Cancer Res. 2000;6:1896–1899
  11. Hsu SL, Chen MC, Chou YH, Hwang GY, Yin SC. Induction of p21(CIP1/Waf1) and activation of p34(cdc2) involved in retinoic acid–induced apoptosis in human hepatoma Hep3B cells. Exp Cell Res. 1999;248:87–96
  12. Pasz-Walczak G, Kordek R. Comparative evaluation of the expression of cell cycle regulating proteins: cyclin D1, P53 and P21 (WAF1) in colorectal cancer. Pol J Pathol. 2000;51:63–69
  13. Schneider J, Presek P, Braun A, Loffler S, Woitowitz HJ. Serum ras (p21) as a marker for occupationally derived lung cancer?. Clin Chem Lab Med. 2000;38:301–305
  14. Koopmann J, Maintz D, Schild S, Schramm J, Louis DN, Wiestler OD, et al. Multiple polymorphisms, but no mutations, in the WAF1/CIP1 gene in human brain tumors. Br J Cancer. 1995;72:1230–1233
  15. Harada K, Ogden GR. An overview of the cell cycle arrest protein, p21(WAF1). Oral Oncol. 2000;36:3–7
  16. Lin CS, Kuo HH, Chen JY, Yang CS, Wang WB. Epstein-Barr virus nuclear antigen 2 retards cell growth, induces p21(WAF1) expression, and modulates p53 activity post-translationally. J Mol Biol. 2000;303:7–23
  17. Woodward TA, Klingler PD, Genko PV, Wolfe JT. Barrett's esophagus, apoptosis and cell cycle regulation: correlation of p53 with Bax, Bcl-2 and p21 protein expression. Anticancer Res. 2000;20:2427–2432
  18. Chen X, Danes C, Lowe M, Herliczek TW, Keyomarsi K. Activation of the estrogen-signaling pathway by p21(WAF1/CIP1) in estrogen receptor–negative breast cancer cells. J Natl Cancer Inst. 2000;92:1403–1413
  19. Kanavaros P, Stefanaki K, Vlachonikolis J, Eliopoulos G, Kakolyris S, Rontogianni D, et al. Expression of p53, p21/waf1, bcl-2, bax, Rb and Ki67 proteins in Hodgkin's lymphomas. Histol Histopathol. 2000;15:445–453
  20. Eisen JA, Hanawalt PC. A phylogenomic study of DNA repair genes, proteins, and processes. Mutat Res. 1999;435:171–213
  21. Lamerdin JE, Montgomery MA, Stilwagen SA, Scheidecker LK, Tebbs RS, Brookman KW, et al. Genomic sequence comparison of the human and mouse XRCC1 DNA repair gene regions. Genomics. 1995;25:547–554
  22. Bu D, Tomlinson G, Lewis CM, Zhang C, Kildebeck E, Euhus DM. An intronic polymorphism associated with increased XRCC1 expression, reduced apoptosis and familial breast cancer. Breast Cancer Res Treat. 2006;99:257–265
  23. Qu T, Morimoto K. X-ray repair cross-complementing group 1 polymorphisms and cancer risks in Asian populations: a mini review. Cancer Detect Prev. 2005;29:215–220
  24. Zhao XH, Jia G, Liu YQ, Liu SW, Yan L, Jin Y, et al. Association between polymorphisms of DNA repair gene XRCC1 and DNA damage in asbestos-exposed workers. Biomed Environ Sci. 2006;19:232–238
  25. van der Straaten T, Kweekel D, Tiller M, Bogaartz J, Guchelaar HJ. Multiplex pyrosequencing of two polymorphisms in DNA repair gene XRCC1. J Mol Diagn. 2006;8:444–448
  26. Monteiro E, Varzim G, Silva R, da Costa B, Lopes C. Polymorphisms of the human OGG1 gene in laryngeal cancer: implications in radiotherapy response and survival. Rev Laryngol Otol Rhinol (Bord). 2005;126:135–140
  27. Karahalil B, Kocabas NA. hOGG1 SER326CYS genetic polymorphism in a Turkish population. Arch Toxicol. 2005;79:377–380
  28. Li L, Miyamoto M, Ebihara Y, Mega S, Takahashi R, Hase R, et al. DRD2/DARPP-32 expression correlates with lymph node metastasis and tumor progression in patients with esophageal squamous cell carcinoma. World J Surg. 2006;30:1672–1679
  29. Hayes G, Biden TJ, Selbie LA, Shine J. Structural subtypes of the dopamine D2 receptor are functionally distinct: expression of the cloned D2A and D2B subtypes in a heterologous cell line. Mol Endocrinol. 1992;6:920–926
  30. Tagliaferri P, Katsaros D, Clair T, Ally S, Tortora G, Neckers L, et al. Synergistic inhibition of growth of breast and colon human cancer cell lines by site selective cAMP analogues. Cancer Res. 1988;48:1642–1650
  31. Lai KC, Chen WC, Jeng LB, Li SY, Chou MC, Tsai FJ. Association of genetic polymorphisms of MK, IL-4, p16, p21, p53 genes and human gastric cancer in Taiwan. Eur J Surg Oncol. 2005;31:1135–1140
  32. Chou IC, Tsai CH, Lee CC, Kuo HT, Hsu YA, Li CI, et al. Association analysis between Tourette's syndrome and dopamine D1 receptor gene in Taiwanese children. Psychiatr Genet. 2004;14:219–221
  33. Lee CC, Chou IC, Tsai CH, Wang TR, Li TC, Tsai FJ. Dopamine receptor D2 gene polymorphisms are associated in Taiwanese children with Tourette syndrome. Pediatr Neurol. 2005;33:272–276
  34. Hsieh YY, Chang CC, Tsai FJ, Hsu CM, Lin CC, Tsai CH. The C-related genotype and allele for E-cadherin 3'-UTR Pml I polymorphism are associated with higher susceptibility to endometriosis. Genet Mol Biol. 2005;28:661–664
  35. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D. p21 is a universal inhibitor of cyclin kinases. Nature. 1993;366:701–704
  36. Gujuluva CN, Baek JH, Shin KH, Cherrick HM, Park NH. Effect of UV-irradiation on cell cycle, viability and the expression of p53, gadd153 and gadd45 genes in normal and HPV-immortalized human oral keratinocytes. Oncogene. 1994;9:1819–1827
  37. Cao L, Yang Z, Li X. Expression and significance of tumor suppressor gene WAF1 in epithelial ovarian neoplasms. Hunan I Ko Ta Hsueh Hsueh Pao. 1998;23:602–604
  38. Huang SP, Wu WJ, Chang WS, Wu MT, Chen YY, Chen YJ, et al. p53 Codon 72 and p21 codon 31 polymorphisms in prostate cancer. Cancer Epidemiol Biomarkers Prev. 2004;13:2217–2224
  39. Su L, Liu G, Zhou W, Xu LL, Miller DP, Park S, et al. No association between the p21 codon 31 serine-arginine polymorphism and lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2003;12:174–175
  40. Roh JW, Kim JW, Park NH, Song YS, Park IA, Park SY, et al. p53 and p21 genetic polymorphisms and susceptibility to endometrial cancer. Gynecol Oncol. 2004;93:499–505
  41. Tsai FJ, Lin HJ, Chen WC, Tsai CH, Tsai SW. A codon 31ser-arg polymorphism of the AF-1/CIP-1/p21/tumour suppressor gene in Chinese primary open-angle glaucoma. Acta Ophthalmol Scand. 2004;82:76–80
  42. Chen WC, Wu HC, Hsu CD, Chen HY, Tsai FJ. p21 gene codon 31 polymorphism is associated with bladder cancer. Urol Oncol. 2002;7:63–66
  43. Chen WC, Lu HF, Chen HY, Hsu CD, Tsai FJ. Arginine form of p21 gene codon 31 is less prominent in patients with calcium oxalate stone. Urol Res. 2001;29:94–97
  44. Tsai MH, Chen WC, Tsai FJ. Correlation of p21 gene codon 31 polymorphism and TNF-alpha gene polymorphism with nasopharyngeal carcinoma. J Clin Lab Anal. 2002;16:146–150
  45. Hsieh YY, Tsai FJ, Chang CC, Chen WC, Tsai CH, Tsai HD, et al. p21 gene codon 31 arginine/serine polymorphism: non-association with endometriosis. J Clin Lab Anal. 2001;15:184–187
  46. Jiao L, Bondy ML, Hassan MM, Wolff RA, Evans DB, Abbruzzese JL, et al. Selected polymorphisms of DNA repair genes and risk of pancreatic cancer. Cancer Detect Prev. 2006;30:284–291
  47. Cao Y, Miao XP, Huang MY, Deng L, Hu LF, Ernberg I, et al. Polymorphisms of XRCC1 genes and risk of nasopharyngeal carcinoma in the Cantonese population. BMC Cancer. 2006;6:167
  48. Park J, Chen L, Tockman MS, Elahi A, Lazarus P. The human 8-oxoguanine DNA N-glycosylase 1 (hOGG1) DNA repair enzyme and its association with lung cancer risk. Pharmacogenetics. 2004;14:103–109
  49. Kim EJ, Jeong P, Quan C, Kim J, Bae SC, Yoon SJ, et al. Genotypes of TNF-alpha, VEGF, hOGG1, GSTM1, and GSTT1: useful determinants for clinical outcome of bladder cancer. Urology. 2005;65:70–75
  50. Tsukino H, Hanaoka T, Otani T, Iwasaki M, Kobayashi M, Hara M, et al. hOGG1 Ser326Cys polymorphism, interaction with environmental exposures, and gastric cancer risk in Japanese populations. Cancer Sci. 2004;95:977–983
  51. Lee YL, Chen W, Tsai WK, Lee JC, Chiou HL, Shih CM, et al. Polymorphisms of p53 and p21 genes in chronic obstructive pulmonary disease. J Lab Clin Med. 2006;147:228–233
  52. Tsai YY, Cheng YW, Lee H, Tsai FJ, Tseng SH, Lin CL, et al. Oxidative DNA damage in pterygium. Mol Vis. 2005;11:71–75
  53. Basu S, Dasgupta PS. Decreased dopamine receptor expression and its second-messenger cAMP in malignant human colon tissue. Dig Dis Sci. 1999;44:916–921
  54. Beige J, Bellmann A, Sharma AM, Gessner R. Ethnic origin determines the impact of genetic variants in dopamine receptor gene (DRD1) concerning essential hypertension. Am J Hypertens. 2004;17:1184–1187
  55. Hansen KA, Zhang Y, Colver R, Tho SP, Plouffe L, McDonough PG. The dopamine receptor D2 genotype is associated with hyperprolactinemia. Fertil Steril. 2005;84:711–718
  56. Kukreti R, Tripathi S, Bhatnagar P, Gupta S, Chauhan C, Kubendran S, et al. Association of DRD2 gene variant with schizophrenia. Neurosci Lett. 2006;392:68–71
  57. Lu Y, Zhu H, Wang X, Snieder H, Huang Y, Harshfield GA, et al. Effects of dopamine receptor type 1 and Gs protein alpha subunit gene polymorphisms on blood pressure at rest and in response to stress. Am J Hypertens. 2006;19:832–836
  58. Shintani S, Matsuo K, Crohin CC, McBride J, Tsuji T, Donoff RB, et al. Intragenic mutation analysis of the human epidermal growth factor receptor (EGFR) gene in malignant human oral keratinocytes. Cancer Res. 1999;59:4142–4147
  59. Kennon B, Ingram MC, Friel EC, Anderson NH, MacKenzie SM, Davies E, et al. Aldosterone synthase gene variation and adrenocortical response to sodium status, angiotensin II and ACTH in normal male subjects. Clin Endocrinol (Oxf). 2004;61:174–181
  60. Shirasawa S, Harada H, Furugaki K, Akamizu T, Ishikawa N, Ito K, et al. SNPs in the promoter of a B cell specific antisense transcript, SAS-ZFAT, determine susceptibility to autoimmune thyroid disease. Hum Mol Genet. 2004;13:2221–2231
  61. Hsieh YY, Wang YK, Chang CC, Lin CS. Estrogen receptor alpha-351 XbaI∗G and -397 PvuII∗C-related genotypes and alleles are associated with higher susceptibilities of endometriosis and leiomyoma. Mol Hum Reprod. 2007;13:117–122
  62. Lee JE, Lee SJ, Namkoong SE, Um SJ, Sull JW, Jee SH, et al. Gene-gene and gene-environmental interactions of p53, p21, and IRF-1 polymorphisms in Korean women with cervix cancer. Int J Gynecol Cancer. 2004;14:118–125
  63. Roh J, Kim M, Kim J, Park N, Song Y, Kang S, et al. Polymorphisms in codon 31 of p21 and cervical cancer susceptibility in Korean women. Cancer Lett. 2001;165:59–62
  64. Powell BL, van Staveren IL, Roosken P, Grieu F, Berns EM, Iacopetta B. Associations between common polymorphisms in TP53 and p21WAF1/Cip1 and phenotypic features of breast cancer. Carcinogenesis. 2002;23:311–315
  65. Bhattacharya P, Sengupta S. Lack of evidence that proline homozygosity at codon 72 of p53 and rare arginine allele at codon 31 of p21, jointly mediate cervical cancer susceptibility among Indian women. Gynecol Oncol. 2005;99:176–182
  66. Li G, Liu Z, Sturgis EM, Shi Q, Chamberlain RM, Spitz MR, et al. Genetic polymorphisms of p21 are associated with risk of squamous cell carcinoma of the head and neck. Carcinogenesis. 2005;26:1596–1602
  67. Xi YG, Ding KY, Su XL, Chen DF, You WC, Shen Y, et al. p53 polymorphism and p21WAF1/CIP1 haplotype in the intestinal gastric cancer and the precancerous lesions. Carcinogenesis. 2004;25:2201–2206
  68. Wu MT, Wu DC, Hsu HK, Kao EL, Yang CH, Lee JM. Association between p21 codon 31 polymorphism and esophageal cancer risk in a Taiwanese population. Cancer Lett. 2003;201:175–180
  69. Ressiniotis T, Griffiths PG, Keers SM, Chinnery PF, Birch M. A polymorphism at codon 31 of gene p21 is not associated with primary open angle glaucoma in Caucasians. BMC Ophthalmol. 2005;5:5
  70. Wu MT, Chen MC, Wu DC. Influences of lifestyle habits and p53 codon 72 and p21 codon 31 polymorphisms on gastric cancer risk in Taiwan. Cancer Lett. 2004;205:61–68
  71. Duarte MC, Colombo J, Rossit AR, Caetano A, Borim AA, Wornrath D, et al. Polymorphisms of DNA repair genes XRCC1 and XRCC3, interaction with environmental exposure and risk of chronic gastritis and gastric cancer. World J Gastroenterol. 2005;11:6593–6600
  72. Shen J, Gammon MD, Terry MB, Wang L, Wang Q, Zhang F, et al. Polymorphisms in XRCC1 modify the association between polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, dietary antioxidants, and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2005;14:336–342
  73. Goodman M, Bostick RM, Ward KC, Terry PD, van Gils CH, Taylor JA, et al. Lycopene intake and prostate cancer risk: effect modification by plasma antioxidants and the XRCC1 genotype. Nutr Cancer. 2006;55:13–20
  74. Chen L, Ambrosone CB, Lee J, Sellers TA, Pow-Sang J, Park JY. Association between polymorphisms in the DNA repair genes XRCC1 and APE1, and the risk of prostate cancer in white and black Americans. J Urol. 2006;175:108–112
  75. Majumder M, Sikdar N, Paul RR, Roy B. Increased risk of oral leukoplakia and cancer among mixed tobacco users carrying XRCC1 variant haplotypes and cancer among smokers carrying two risk genotypes: one on each of two loci, GSTM3 and XRCC1 (codon 280). Cancer Epidemiol Biomarkers Prev. 2005;14:2106–2112
  76. Stern MC, Siegmund KD, Corral R, Haile RW. XRCC1 and XRCC3 polymorphisms and their role as effect modifiers of unsaturated fatty acids and antioxidant intake on colorectal adenomas risk. Cancer Epidemiol Biomarkers Prev. 2005;14:609–615
  77. Joseph T, Kusumakumary P, Chacko P, Abraham A, Pillai MR. DNA repair gene XRCC1 polymorphisms in childhood acute lymphoblastic leukemia. Cancer Lett. 2005;217:17–24
  78. Ratnasinghe LD, Abnet C, Qiao YL, Modali R, Stolzenberg-Solomon R, Dong ZW, et al. Polymorphisms of XRCC1 and risk of esophageal and gastric cardia cancer. Cancer Lett. 2004;216:157–164
  79. Yu HP, Zhang XY, Wang XL, Shi LY, Li YY, Li F, et al. DNA repair gene XRCC1 polymorphisms, smoking, and esophageal cancer risk. Cancer Detect Prev. 2004;28:194–199
  80. Duell EJ, Holly EA, Bracci PM, Wiencke JK, Kelsey KT. A population-based study of the Arg399Gln polymorphism in X-ray repair cross complementing group 1 (XRCC1) and risk of pancreatic adenocarcinoma. Cancer Res. 2002;62:4630–4636
  81. Yu MW, Yang SY, Pan IJ, Lin CL, Liu CJ, Liaw YF, et al. Polymorphisms in XRCC1 and glutathione S-transferase genes and hepatitis B-related hepatocellular carcinoma. J Natl Cancer Inst. 2003;95:1485–1488
  82. Mertens AC, Mitby PA, Radloff G, Jones IM, Perentesis J, Kiffmeyer WR, et al. XRCC1 and glutathione-S-transferase gene polymorphisms and susceptibility to radiotherapy-related malignancies in survivors of Hodgkin disease. Cancer. 2004;101:1463–1472
  83. Varzim G, Monteiro E, Silva RA, Fernandes J, Lopes C. CYP1A1 and XRCC1 gene polymorphisms in SCC of the larynx. Eur J Cancer Prev. 2003;12:495–499
  84. Kau HC, Tsai CC, Hsu WM, Liu JH, Wei YH. Genetic polymorphism of hOGG1 and risk of pterygium in Chinese. Eye. 2004;18:635–639
  85. Cho EY, Hildesheim A, Chen CJ, Hsu MM, Chen IH, Mittl BF, et al. Nasopharyngeal carcinoma and genetic polymorphisms of DNA repair enzymes XRCC1 and hOGG1. Cancer Epidemiol Biomarkers Prev. 2003;12:1100–1104
  86. Poplawski T, Arabski M, Kozirowska D, Blasinska-Morawiec M, Morawiec Z, Morawiec-Bajda A, et al. DNA damage and repair in gastric cancer-A correlation with the hOGG1 and RAD51 genes polymorphisms. Mutat Res. 2006;601:83–91
  87. Hu YC, Ahrendt SA. hOGG1 Ser326Cys polymorphism and G:C-to-T:A mutations: no evidence for a role in tobacco-related non small cell lung cancer. Int J Cancer. 2005;114:387–393
  88. Park YJ, Choi EY, Choi JY, Park JG, You HJ, Chung MH. Genetic changes of hOGG1 and the activity of oh8Gua glycosylase in colon cancer. Eur J Cancer. 2001;37:340–346
  89. Liang G, Pu Y, Yin L. Rapid detection of single nucleotide polymorphisms related with lung cancer susceptibility of Chinese population. Cancer Lett. 2005;223:265–274
  90. Wang CL, Hsieh MC, Hsin SC, Lin HY, Lin KD, Lo CS, et al. The hOGG1 Ser326Cys gene polymorphism is associated with decreased insulin sensitivity in subjects with normal glucose tolerance. J Hum Genet. 2006;51:124–128
  91. Dmitrzak-Weglarz M, Rybakowski JK, Slopien A, Czerski PM, Leszczynska-Rodziewicz A, Kapelski P, et al. Dopamine receptor D1 gene-48A/G polymorphism is associated with bipolar illness but not with schizophrenia in a Polish population. Neuropsychobiology. 2006;53:46–50
  92. Misener VL, Luca P, Azeke O, Crosbie J, Waldman I, Tannock R, et al. Linkage of the dopamine receptor D1 gene to attention-deficit/hyperactivity disorder. Mol Psychiatry. 2004;9:500–509
  93. Kojima H, Ohmori O, Shinkai T, Terao T, Suzuki T, Abe K. Dopamine D1 receptor gene polymorphism and schizophrenia in Japan. Am J Med Genet. 1999;88:116–119
  94. Gelernter J, Pauls DL, Leckman J, Kidd KK, Kurlan R. D2 dopamine receptor alleles do not influence severity of Tourette's syndrome. Results from four large kindreds. Arch Neurol. 1994;51:397–400

 Chi-Chen Chang, Da-Tian Bau, and Yao-Yuan Hsieh contributed equally to this work.

PII: S0015-0282(07)02959-7

doi: 10.1016/j.fertnstert.2007.07.1328

Fertility and Sterility
Volume 91, Issue 3 , Pages 869-877 , March 2009

Article Tools

* Image Usage & Resolution